Biggest News Aggregation in the World
📰 Genome Aggregation Database News

Page 2 - Genome Aggregation Database News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Genome Aggregation Database. Real-time updates on events, politics, business and more.

Frontiers | Concurrent Newborn Hearing and Genetic Screening in a Multi-Ethnic Population in South China

Hearing loss is a common sensory deficit in humans with intricate genomic landscape and mutational signature. Approximately 1 - 3 out of 1,000 newborns have hearing loss and up to 60% of these cases have a genetic etiology. In this study, we conducted the concurrent newborn hearing and genetic screening in 20 mutations in GJB2, GJB3, SLC26A4 and MT-RNR1 for 9,506 normal newborns (4,977 [52.4%] males) from 22 ethnic population in South China. A total of 1,079 (11.4%) newborns failed to pass the i...
United States Eteläuomen Läi South Korea J Pediatr Otorhinolaryngol Qixuan Wang Ann Otol Rhinol Laryngol

Researchers identify new gene variants that may cause inherited retinal dystrophies

An international team of researchers, led by scientists at University of California San Diego and Shiley Eye Institute at UC San Diego Health, has broadened and deepened understanding of how inherited retinal dystrophies (IRDs) affect different populations of people and, in the process, have identified new gene variants that may cause the diseases.
San Diego United States University Of California San Diego Emily Henderson Uc San Diego Health Shiley Eye Institute

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper Histidinate, Presented at 2021 American Academy of Pediatrics National Conference & Exhibition

/PRNewswire/ -- Cyprium Therapeutics, Inc. ("Cyprium"), a Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress") partner company, with support from its licensing...
United States New York Michael Chen Tony Plohoros Michael Hercz Jaclyn Jaffe

Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper Histidinate, Presented at 2021 American Academy of Pediatrics National Conference & Exhibition

Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper Histidinate, Presented at 2021 American Academy of Pediatrics National Conference & Exhibition - read this article along with other careers information, tips and advice on BioSpace
United States New York Michael Chen Tony Plohoros Michael Hercz Jaclyn Jaffe

Study explores how human ACE2 variants can modify SARS-CoV-2 binding

Study explores how human ACE2 variants can modify SARS-CoV-2 binding A recent tour-de-force study by researchers from the United Kingdom reveals variants of the human angiotensin-converting enzyme 2 (ACE2) that can improve or decrease binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – including two variants with distinct population distributions showing an enhanced affinity for viral spike glycoprotein. This research paper is currently available on the bioRxiv* pre...
United Kingdom Stuarta Macgowan Geoffreyj Barton Division Of Computational Biology Senior Bioinformatics Research Scientist Dr Image Credit

Amazon Web Services doubles down on genomics

Amazon Web Services doubles down on genomics Neil Versel, Genomeweb Getty Images Amazon Web Services has been expanding its reach into genomics and continues to grow in areas like molecular diagnostics through new initiatives. As might be expected of one of the worlds three largest commercial cloud platforms, AWS counts some well-known names in the genomics and bioinformatics world among its customers. "Over the past 15 years, AWS has helped remove the undifferentiated heavy lifting so that cus...
Pat Combs Development Initiative Munich Leukemia Laboratory Healthcare Life Sciences Virtual Symposium Amazon Web Services Life Sciences Virtual

Fortress Biotech Reports Record 2020 Financial Results and Recent Corporate Highlights

Our six dermatology products are marketed by our partner company, Journey Medical Corporation (“Journey”). Our products generated net revenues of $44.5 million for full-year 2020, compared to full-year 2019 net revenues of $34.9 million, representing growth of 28%. Our products generated $13.7 million in revenues in the fourth quarter of 2020, compared to $11.1 million in the fourth quarter of 2019, representing growth of 23%. While we generated revenue growth year-over-year in 2020, sales ...
United States Fred Hutch Samsung Biologics Lindsaya Rosenwald International Symposium On Amyloidosis American Society Of Hematology Annual Meeting

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science